In conclusion, the obtained results have indicated that exosomal FZD7 correlates with worsening of NAFLD and consistent improvements following different lifestyle interventions, suggesting a role for FZD7 as a potential non-invasive biomarker for NAFLD management. The gene discussed is FZD7; the disease is metabolic dysfunction-associated steatotic liver disease.